Article Sidebar

Submitted
14 January 2021
Accepted
14 January 2021
Published
30 June 2019
Download
PDF
Statistic
Read Counter : 513 Download : 629

Main Article Content

Abstract

In the case of advanced stage gynecological disorders, most patients have a disturbance in the upper urinary tract. Most patients with uterine cervical carcinoma are already in stage 3B and require urine diversion. The purpose of this study is to find and determine the profile of gynecological disorders that require urine diversion, the type of urine diversion, and urine diverted output in patients with cervical carcinoma. This descriptive analytical retrospective study was conducted at Dr. Soetomo Hospital, Surabaya, Indonesia, between 2012 and 2015. The samples of this study were all patients with gynecological disorders who underwent retrograde DJ stent procedures, underwent ureterocutaneostomy and nephrostomy at the Integrated Central Surgery Building, Dr. Soetomo Hospital, Surabaya, for three years between 2012 and 2015. Data was collected based on the medical record number of patients with gynecological disorders who underwent urine diversion procedures and were recorded in the book on the operation schedule. We find that the most common cause of gynecological abnormalities in kidney obstruction is cervical carcinoma. There are three types of urine diversions used, namely DJ stent, percutaneous nefropyelostomy, and ureterocutaneostomy, with DJ as the most commonly performed. Urine diversion can improve creatinine without being influenced by the type of diversity.

Keywords

Gynecological abnormalities urine diversion DJ stent nephropyelostomy ureterocutaneostomy

Article Details

License

Copyright (c) 2019 Folia Medica Indonesiana

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

  • Folia Medica Indonesiana is a scientific peer-reviewed article which freely available to be accessed, downloaded, and used for research purposes. Folia Medica Indonesiana (p-ISSN: 2541-1012; e-ISSN: 2528-2018) is licensed under a Creative Commons Attribution 4.0 International License. Manuscripts submitted to Folia Medica Indonesiana are published under the terms of the Creative Commons License. The terms of the license are:

    Attribution ” You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

    NonCommercial ” You may not use the material for commercial purposes.

    ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.

    No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

    You  are free to :

    Share ” copy and redistribute the material in any medium or format.

    Adapt ” remix, transform, and build upon the material.

How to Cite
Soetojo, S., & Nurdin, A. T. (2019). Charateristics of Gynecological Abnormalities and Types of Urine Diversion at Dr Soetomo Hospital, Surabaya, Indonesia, in Three-Year Period. Folia Medica Indonesiana, 55(2), 134–138. https://doi.org/10.20473/fmi.v55i2.24617
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX

References

  1. Aziz MF (2009). Gynecological cancer in Indonesia. Journal Gynecol Onco 20, 8-10
  2. Danilovic A, Antonopoulus IM, Mesquita JL (2005). Likelihood of retrograde double-J stenting according to ureteral obstructing pathology. International Braz J Urol 31, 431-36
  3. Gumilar OB, Soebadi DM, Tarmono, Askandar B, Pudjirahardjo WJ (2012). Oral phenazopyridine HCl for ureter orifice identification and retrograde stenting. Unpublished
  4. Hewitson TD (2009). Renal tubulointersitial fibrosis: common but never simple. Am J Physiol Renal Physiol 296, 1239-44
  5. Kanou T, Fujiyama C, Nishimura K, Tokuda Y, Uozumi J, Masaki Z (2007). Management of extrinsic malignant ureteral obstruction with urinary diversion. International Journal of Urology 14, 689-92
  6. Kouba E, Wallen EM, Pruthi RS (2008). Management of ureteral obstruction due to advanced malignancy : Optimizing therapeutic and palliative outcomes. The Journal of Urology 180, 444-50.
  7. Olivera ST, Gjulsen S, Katica Z (2010). Obstructive nephropathy as a result of malignant neoplasms: A single centre experience. BANTAO Journal 8, 71-74
  8. RSUD Dr Soetomo (2010). Data pasien kanker mulut rahim Poli Ginekologi Onkologi RSUD Dr. Soetomo Surabaya
  9. Russo P (2000). Urological emergency in the cancer patient. Seminars in Oncology 27, 284
  10. Singh I, Strandhoy JW, Assimos DG (2012). Patophysiology of urinary tract obstruction. In: Campbell-Walsh Urology. 10th ed. Philadelphia, Elsevier Saunders, p 1087-121
  11. Sundar S, Horne A, Kehoe S (2008). Cervical cancer. BMJ Clinical Evidence 3, 818
  12. Yossepowitch O, Lifshitz DA, Dekel Y, Gross M, Keidar DM, Neuman M, et al (2001). Predicting the success of retrograde stenting for managing ureteral obstruction. J Urol 166, 1746-9